Literature DB >> 29380238

Activating adenosine A1 receptor accelerates PC12 cell injury via ADORA1/PKC/KATP pathway after intermittent hypoxia exposure.

Hong-Fang Mei1,2, Neha Poonit1, Yi-Chun Zhang1, Chu-Yuan Ye1, Hui-Lin Cai1, Chen-Yi Yu1, Yong-Hai Zhou1, Bei-Bei Wu1, Jun Cai3,4, Xiao-Hong Cai5.   

Abstract

Obstructive sleep apnea hypopnea syndrome (OSAHS) is associated with the neurocognitive deficits as a result of the neuronal cell injury. Previous studies have shown that adenosine A1 receptor (ADORA1) played an important role against hypoxia exposure, such as controlling the metabolic recovery in rat hippocampal slices and increasing the resistance in the combined effects of hypoxia and hypercapnia. However, little is known about whether ADORA1 takes part in the course of neuronal cell injury after intermittent hypoxia exposure which was the main pathological characteristic of OSAHS. The present study is performed to explore the underlying mechanism of neuronal cell injury which was induced by intermittent hypoxia exposure in PC12 cells. In our research, we find that the stimulation of the ADORA1 by CCPA accelerated the injury of PC12 cells as well as upregulated the expression of PKC, inwardly rectifying potassium channel 6.2(Kir6.2) and sulfonylurea receptor 1(SUR1) while inhibition of the ADORA1 by DPCPX alleviated the injury of PC12 cells as well as downregulated the expression of PKC, Kir6.2, and SUR1. Moreover, inhibition of the PKC by CHE, also mitigated the injury of PC12 cells, suppressed the Kir6.2 and SUR1 expressions induced by PKC. Taken together, our findings indicate that ADORA1 accelerated PC12 cells injury after intermittent hypoxia exposure via ADORA1/PKC/KATP signaling pathway.

Entities:  

Keywords:  ATP-sensitive potassium channel; Adenosine A1 receptor; Intermittent hypoxia; Obstructive sleep apnea hypopnea syndrome; Protein kinase C

Mesh:

Substances:

Year:  2018        PMID: 29380238     DOI: 10.1007/s11010-018-3283-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  55 in total

1.  Adenosine and inosine release during hypoxia in the isolated spinal cord of neonatal rats.

Authors:  T Takahashi; K Otsuguro; T Ohta; S Ito
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

2.  Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure.

Authors:  K Yamada; J J Ji; H Yuan; T Miki; S Sato; N Horimoto; T Shimizu; S Seino; N Inagaki
Journal:  Science       Date:  2001-05-25       Impact factor: 47.728

3.  Neuronal K(ATP) channels mediate hypoxic preconditioning and reduce subsequent neonatal hypoxic-ischemic brain injury.

Authors:  Hong-Shuo Sun; Baofeng Xu; Wenliang Chen; Aijiao Xiao; Ekaterina Turlova; Ammar Alibraham; Andrew Barszczyk; Christine Y J Bae; Yi Quan; Baosong Liu; Lin Pei; Christopher L F Sun; Marielle Deurloo; Zhong-Ping Feng
Journal:  Exp Neurol       Date:  2014-10-18       Impact factor: 5.330

4.  Adenosine A1 receptor activation is arrhythmogenic in the developing heart through NADPH oxidase/ERK- and PLC/PKC-dependent mechanisms.

Authors:  Elodie Robin; Jessica Sabourin; Rachel Benoit; Sarah Pedretti; Eric Raddatz
Journal:  J Mol Cell Cardiol       Date:  2011-08-31       Impact factor: 5.000

5.  [Expression of KATP in pulmonary artery smooth muscle cells under hypoxia-hypercapnia condition and the relationship with p38 MAPK pathway].

Authors:  Ying-Chun Ma; Lin-Jing Huang; Meng-Xiao Zheng; Yuan-Yuan Wang; Lei Ying; Wan-Tie Wang
Journal:  Sheng Li Xue Bao       Date:  2014-06-25

6.  Adenosine analogues prevent phorbol ester-induced PKC depletion in porcine coronary artery via A1 receptor.

Authors:  R B Marala; S J Mustafa
Journal:  Am J Physiol       Date:  1995-01

7.  [Continuous positive airway pressure treatment for functional cardiac arrhythmias combined with obstructive sleep apnea hypopnea syndrome].

Authors:  Liu Jianyong; Lu Jianbin; Li Menglin; Xu Yue; Yang Qi; Yuan Yifang; Yu Yan; Ye Jingying
Journal:  Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi       Date:  2015-03

8.  Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy.

Authors:  S Daniele; E Zappelli; L Natali; C Martini; M L Trincavelli
Journal:  Cell Death Dis       Date:  2014-11-27       Impact factor: 8.469

9.  Obstructive Sleep Apnea, Hypertension, and Their Additive Effects on Atherosclerosis.

Authors:  Mario Francesco Damiani; Annapaola Zito; Pierluigi Carratù; Vito Antonio Falcone; Elioda Bega; Pietro Scicchitano; Marco Matteo Ciccone; Onofrio Resta
Journal:  Biochem Res Int       Date:  2015-12-01

10.  Omega-3 PUFAs induce apoptosis of gastric cancer cells via ADORA1.

Authors:  Hong Sheng; Pu Li; Xuehua Chen; Binya Liu; Zhenggang Zhu; Weixin Cao
Journal:  Front Biosci (Landmark Ed)       Date:  2014-06-01
View more
  5 in total

Review 1.  The role of adenosine A1 receptor on immune cells.

Authors:  Lingyu Zhong; Qiao Peng; Xun Zeng
Journal:  Inflamm Res       Date:  2022-09-05       Impact factor: 6.986

2.  Potential biomarkers for inflammatory response in acute lung injury.

Authors:  Lanzhi Zheng; Zhuoyi Zhang; Kang Song; Xiaoyang Xu; Yixin Tong; Jinling Wei; Lu Jiang
Journal:  Open Med (Wars)       Date:  2022-06-08

3.  Effect of Adenosine Receptor Antagonists on Adenosine-Pretreated PC12 Cells Exposed to Paraquat.

Authors:  Liangcheng Shang; Yaobiao Huang; Xin Xie; Sudan Ye; Chun Chen
Journal:  Dose Response       Date:  2022-04-09       Impact factor: 2.658

Review 4.  Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?

Authors:  Tiziana Vaisitti; Francesca Arruga; Silvia Deaglio
Journal:  Int J Mol Sci       Date:  2018-04-12       Impact factor: 5.923

5.  Neuroprotective Effects of Adenosine A1 Receptor Signaling on Cognitive Impairment Induced by Chronic Intermittent Hypoxia in Mice.

Authors:  Yichun Zhang; Hongchao Cao; Xuehao Qiu; Danfen Xu; Yifeng Chen; Gregory N Barnes; Yunjia Tu; Adwoa Takyiwaa Gyabaah; Abdulla Husain Abdulla Ahmed Gharbal; Chenlei Peng; Jun Cai; Xiaohong Cai
Journal:  Front Cell Neurosci       Date:  2020-07-09       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.